← back to search

Youyou Li

Guiyang Medical University · CN
Area of research
Biomedical Engineering · Inorganic Chemistry
Research interest
Research interests include Nanoplatforms for cancer theranostics, Metal-Organic Frameworks: Synthesis and Applications, Nanoparticle-Based Drug Delivery, and Remote-Sensing Image Classification.
h-index
15
citations
780
works
52
NIH funding
primary concept
email

Recent publications

Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy
Advanced Science 2024cited by 112position: firstdoi
Mitochondria‐Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death‐1 Downregulation for Cancer Immunotherapy
Advanced Science 2024cited by 46position: firstdoi
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy
ACS Nano 2024cited by 25position: middledoi
A robust and ultra-high-surface hydrogen-bonded organic framework promoting high-efficiency solid phase microextraction of multiple persistent organic pollutants from beverage and tea
Food Chemistry 2023cited by 42position: middledoi
A self-assembled nanophotosensitizer targets lysosomes and induces lysosomal membrane permeabilization to enhance photodynamic therapy
Chemical Science 2023cited by 29position: firstdoi
Platinum-based combination nanomedicines for cancer therapy
Current Opinion in Chemical Biology 2023cited by 18position: firstdoi
Tumor‐Activatable Nanoparticles Target Low‐Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy
Advanced Science 2022cited by 39position: middledoi
Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy
Biomaterials 2021cited by 99position: middledoi
Nanoscale Metal–Organic Layers Detect Mitochondrial Dysregulation and Chemoresistance via Ratiometric Sensing of Glutathione and pH
Journal of the American Chemical Society 2021cited by 60position: middledoi
Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity
ACS Nano 2020cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wenbin Lin · Guangdong University of Technology9 papers (2020–2024)Ralph R. Weichselbaum · University of Chicago Medical Center4 papers (2022–2024)Wenbo Han · Central South University3 papers (2020–2022)Xiaomin Jiang · Ludwig Cancer Research3 papers (2020–2024)Ziwan Xu · Ministry of Education of the People's Republic of China3 papers (2020–2022)Megan Rodriguez · Abterra Biosciences (United States)2 papers (2020–2022)Jianming Mao · Fujian Medical University2 papers (2022–2023)Deyan Gong · Hefei University of Technology2 papers (2021–2023)Xiang Ling · Roswell Park Comprehensive Cancer Center2 papers (2020–2021)Kaiting Yang · University of Illinois Chicago2 papers (2022–2024)Wenwu Qin · Guangxi University2 papers (2021–2023)Taokun Luo · International Institute for Nanotechnology2 papers (2022–2023)Jianqiao Liu · Central South University1 papers (2022–2022)Christina Chan · University of Chicago1 papers (2021–2021)Yimei Chen · Jiangnan University1 papers (2024–2024)Marc Bissonnette · University of Chicago1 papers (2022–2022)Jing Liu · Gansu University of Traditional Chinese Medicine1 papers (2024–2024)Yixin Kuang · Sun Yat-sen University1 papers (2023–2023)Fang Zhu · Jiangsu University1 papers (2023–2023) · 1 papers (2023–2023)